News

Combination of a pioneering traceability provider and a leading consulting firm

Multiple locations in Mexico and Brazil can now be served more quickly

Three more locations join continents

Acquisition of daVIZta brings more analytics expertise

Company touts 12 months of rapid growth

The advantages of aligning patient recruitment and supply data

Rupture happens at a crucial time in Washington for the pharma industry

Presidential campaigns only magnify an already intense debate

$21.4-billion acquisition realigns research and manufacturing sourcing

Regulation enables better coordination of where opioids are going

The goal of producing meaningful data is driving industry progress

Agency tries to get a handle on cross-border trade

Ex-AmerisourceBergen, -Cardinal and -inVentiv Health execs join team

By working with the sales force, incentive plan design can boost a product launch

Issues include apparently diverted opioids and mislabeled medications

As the definition of ‘targeted’ therapies—especially in oncology—and as a component of companion diagnostics, biomarkers are creating opportunities in drug research and commercialization

Smart tag connects onboard intelligence with smartphone

30-day deadline for making an application to participate; in the EU, the FMD program is progressing

Diligent Health Solutions banks on experienced management

Will restricting use of rebates in federal programs carry over to commercial insurance?

A marketing challenge: how to make more adults aware of anti-bacterial booster shots

Expansions in the capability of supply chain participants to manage temperature-controlled pharmaceuticals

Senate and House committees begin the legislative process for addressing drug pricing

Annual analysis predicts 3-6% CAGR through 2023, a lower rate than 2014-2018

Even as the science behind the new therapies is getting established, payers are preparing for their extraordinary cost

Broader capabilities for refrigerated or cryogenic transport of cellular materials

Signs up Bayer Health for pulmonary hypertension and MS

Nov. 27, 2018, was to be a red-letter day in the 10-year program to implement an end-to-end pharma traceability system. Did industry meet the deadline?